qCT-Lung
Qure.aiProduct specifications |
Information source:
Vendor
Last updated: March 25, 2023 |
General | |
---|---|
Product name | qCT-Lung |
Company | Qure.ai |
Subspeciality | Chest |
Modality | CT |
Disease targeted | Lung cancer, emphysema |
Key-features | Lung nodule detection, emphysema detection |
Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps) |
Data characteristics | |
Population | Chest CTs for adults (age >= 18 years) |
Input | Non-contrast chest CTs, consistently spaced axial slices, soft reconstruction kernel, maximum slice thickness of 6 mm, minimum of 40 axial slices |
Input format | DICOM |
Output | Image annotation overlay |
Output format | DICOM secondary capture, PDF |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | 1 - 10 minutes |
Certification | |
CE
|
Certified,
Class IIb
, MDR
|
FDA
|
No or not yet |
Market presence | |
On market since | 08-2021 |
Distribution channels | |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Pay-per-use, Subscription |
Based on | Number of installations, Number of analyses |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |